Coronary Microcirculatory and Bioresorbable Vascular Scaffolds

Exclusion Criteria

• •1. Patients with confirmed myocardial infarction within the preceding 2 months.
• •2. Allergy or intolerance to aspirin, clopidogrel, prasugrel or ticagrelor or contraindication to 12 months' dual antiplatelet therapy.
• •3. Contraindication to use of adenosine (asthma/chronic lung disease with documented bronchoreactivity).
• •4. Significant known comorbidity or terminal condition with life expectancy \<6 months.
• •5. Pregnancy.
• •6. Coagulopathy or warfarin treatment.
• •7. Significant renal impairment (baseline creatinine\>130 mmol/l).
• •8. Other comorbid condition that may affect microcirculatory function or troponin release (eg. Seropositive inflammatory conditions).
• •9. Inability to comply with follow-up requirements.
• •10. Target lesion in left mainstem, saphenous vein or arterial grafts.
• •11. Chronic total occlusion.